Overall, our results identify LCN2 exhibits a strong tumor-suppressive effect by acting as a new upstream inhibitor of the NF-κB/snail pathway to control colorectal cancer progression, and suggest promising applications for LCN2/NF-ĸB/snail pathway as novel prognostic, and therapeutic strategies for colorectal cancer. The gene discussed is SNAI1; the disease is neoplasm.